These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9050950)

  • 1. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
    Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C
    Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancer.
    Geisler J; Haarstad H; Gundersen S; Raabe N; Kvinnsland S; Lønning PE
    J Endocrinol; 1995 Aug; 146(2):359-63. PubMed ID: 7561649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients.
    Lønning PE; Johannessen DC; Lien EA; Ekse D; Fotsis T; Adlercreutz H
    J Steroid Biochem Mol Biol; 1995 May; 52(5):491-6. PubMed ID: 7748814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
    Kyvernitakis I; Albert US; Kalder M; Winarno AS; Hars O; Hadji P
    Climacteric; 2015 Feb; 18(1):63-8. PubMed ID: 24884402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients.
    Geisler J; Ekse D; Hösch S; Lønning PE
    J Steroid Biochem Mol Biol; 1995 Nov; 55(2):193-5. PubMed ID: 7495698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
    Ellmén J; Hakulinen P; Partanen A; Hayes DF
    Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal effects of toremifene in breast cancer patients.
    Számel I; Vincze B; Hindy I; Kerpel-Fronius S; Eckhardt S; Mäenpää J; Grönroos M; Kangas L; Sundquist H; Hajba A
    J Steroid Biochem; 1990 Jun; 36(3):243-7. PubMed ID: 2142246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer.
    Számel I; Vincze B; Hindy I; Hermann I; Borvendég J; Eckhardt S
    Oncology; 1986; 43(1):7-11. PubMed ID: 3079899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.
    Wayne S; Neuhouser ML; Ulrich CM; Koprowski C; Wiggins C; Baumgartner KB; Bernstein L; Baumgartner RN; Gilliland F; McTiernan A; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3224-32. PubMed ID: 18957523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentration of selected sex hormones and SHBG in the serum of women with breast cancer treated with antiestrogens and (or) cytostatic agents].
    Grodecka-Gazdecka S; Kociałkowski K
    Nowotwory; 1990; 40(1):5-11. PubMed ID: 2356147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
    Schieferstein G; Adam W; Armann J; Bantel E; Cörlin R; Egenrieder H; Fierlbeck G; Hook B; Schiek A; Schubring G
    Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.
    Jordan VC; Fritz NF; Langan-Fahey S; Thompson M; Tormey DC
    J Natl Cancer Inst; 1991 Oct; 83(20):1488-91. PubMed ID: 1920495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
    Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.
    Johansson H; Bonanni B; Gandini S; Guerrieri-Gonzaga A; Cazzaniga M; Serrano D; Macis D; Puccio A; Sandri MT; Gulisano M; Formelli F; Decensi A
    Breast Cancer Res Treat; 2013 Dec; 142(3):569-78. PubMed ID: 24241787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years.
    Jiroutek MR; Chen MH; Johnston CC; Longcope C
    Menopause; 1998; 5(2):90-4. PubMed ID: 9689202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.